NR3C2 rs5522: Understanding the Mineralocorticoid Receptor Variant
The rs5522 variant is a genetic change located within the NR3C2 gene, which encodes the mineralocorticoid receptor. Research has investigated its potential associations with autonomic stress responses, blood pressure regulation, and cardiovascular health.
What each genotype means
Iso homozygote
This genotype corresponds to the isoleucine (Iso) variant of the mineralocorticoid receptor. Research suggests that individuals with this genotype may show increased amygdala reactivity specifically in the context of a history of childhood emotional neglect. This association is based on limited evidence and reflects complex interactions between genetics and early life environment.
This genotype is common in many populations, though exact frequencies vary by ancestry.
Iso/Val heterozygote
This genotype represents a mix of the isoleucine (Iso) and valine (Val) variants of the mineralocorticoid receptor. Studies indicate that the Val allele is associated with greater amygdala reactivity, and this effect may be observed independently of childhood emotional neglect. As this is a complex trait, these findings represent statistical associations in research cohorts rather than individual clinical predictions.
This is a common heterozygous genotype found in diverse populations globally.
Val homozygote
This genotype corresponds to the valine (Val) variant of the mineralocorticoid receptor. Research has associated the Val allele with greater amygdala reactivity, which may occur independently of a history of childhood emotional neglect. Because this variant is involved in stress response pathways, these associations are considered limited and context-dependent.
The G allele has a minor allele frequency of approximately 0.09–0.15 in European and American cohorts, making this homozygous genotype less common than the others.
What is the rs5522 Variant?
The rs5522 variant is a single nucleotide polymorphism (SNP) situated within the NR3C2 gene on chromosome 4. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is often referred to in scientific literature as the I180V polymorphism, reflecting a change in the amino acid sequence of the resulting protein. Because humans inherit two copies of every gene—one from each parent—individuals can possess different combinations of the genetic letters at this location. These combinations determine an individual's genotype for this specific site. Scientists study these variations to understand how subtle differences in our genetic code might influence biological processes, such as how our bodies respond to environmental stressors or maintain fluid balance.
The Role of the NR3C2 Gene
The NR3C2 gene provides the instructions for building the mineralocorticoid receptor (MR) protein. This receptor acts as a ligand-dependent transcription factor, meaning it binds to specific hormones—such as aldosterone and cortisol—and then enters the cell nucleus to turn certain genes on or off. The MR is essential for maintaining salt and water balance in the body, which directly influences blood pressure regulation. Beyond its role in the kidneys, the mineralocorticoid receptor is also active in the brain, where it plays a critical part in the initial triggering of the body's stress response system. By modulating how cells respond to hormonal signals, the NR3C2 gene helps the body adapt to physiological and psychological challenges, making it a subject of interest in studies regarding cardiovascular health and behavioral phenotypes.
Research and Evidence Strength
The evidence linking rs5522 to specific health outcomes is currently considered limited and mixed. Some studies have explored whether this variant influences susceptibility to conditions like resistant hypertension or attention-deficit/hyperactivity disorder (ADHD), with researchers looking for correlations between the variant and physiological markers like aldosterone levels or cardiac remodeling. For instance, some data have suggested that carriers of certain alleles might show differences in ambulatory blood pressure or left ventricular mass index. However, other studies have found no significant differences in allele frequencies between hypertensive and control groups. Because these findings are often based on small cohorts or specific clinical populations, they do not establish a definitive cause-and-effect relationship. The scientific community continues to investigate these associations, but current evidence is not sufficient to use this variant as a predictive tool for clinical diagnosis.
Population Frequency
The rs5522 variant is relatively common, with a minor allele frequency typically reported between 0.09 and 0.15 in European and American cohorts. This means that a significant portion of the population carries at least one copy of the variant allele. Because the frequency varies across different ancestral groups, it is important to consider population-specific data when interpreting genetic studies. The distribution of genotypes—whether an individual is homozygous for the common allele, homozygous for the variant, or heterozygous—follows standard patterns of inheritance. While these frequencies are well-documented in genomic databases, they do not inherently imply that the variant is harmful or beneficial; rather, they reflect the natural genetic diversity present within human populations.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs5522 are only one piece of a much larger biological puzzle. Most complex traits and health conditions are influenced by a combination of many different genes, as well as environmental factors, lifestyle choices, and medical history. Having a particular genotype for rs5522 does not mean you will develop a specific condition, nor does it guarantee protection against one. If you are interested in how your genetics might relate to your cardiovascular health or stress response, this information should be discussed with a qualified healthcare professional. Never use genetic data to make independent medical decisions or to alter prescribed treatments. Always consult your clinician or pharmacist regarding any concerns about medication response or health management, as they can provide context based on your full clinical profile.
How common is this variant?
The minor allele frequency for rs5522 is approximately 0.09–0.15 in European and American cohorts, making it a relatively common genetic variation.
Frequently asked questions
Is rs5522 a diagnostic test for hypertension?
No, rs5522 is not a diagnostic test for hypertension. While some research has explored associations between this variant and blood pressure regulation, it is not used in clinical practice to diagnose or predict the development of high blood pressure.
Can I use this information to change my medication?
You should never change your medication based on genetic information alone. Always discuss your genetic results and any concerns about your treatment plan with your doctor or pharmacist, who can provide guidance based on your complete medical history.
What does the NR3C2 gene do?
The NR3C2 gene encodes the mineralocorticoid receptor, which is a protein that helps regulate salt and water balance in the body. It also plays a role in the brain's response to stress by binding to hormones like cortisol and aldosterone.
Is the rs5522 variant considered harmful?
The rs5522 variant is not classified as inherently harmful. It is a common genetic variation, and current research into its health implications is mixed and limited, meaning it does not have a clear 'good' or 'bad' clinical status.
Sources & further reading
Educational information only, last refreshed 10/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs5522?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NR3C2
Functional mineralocorticoid receptor variant influencing basal cortisol secretion.
An exon variant (Ile180Val) in the mineralocorticoid receptor gene that modulates receptor transactivation capacity and influences autonomic reactivity under acute cognitive stress.
A polymorphism in the mineralocorticoid receptor gene associated with spontaneous preterm birth, suggesting a genetic influence on stress-related pregnancy complications.
This variant in the mineralocorticoid receptor gene is significantly associated with an altered risk of spontaneous preterm birth, potentially linking maternal stress response genetics to pregnancy outcomes.